Global Cancer Hormone Therapy Drugs Market Growth (Status and Outlook) 2022-2028

January 2021 | 104 pages | ID: GF78B4A9CB8EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Cancer Hormone Therapy Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Cancer Hormone Therapy Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cancer Hormone Therapy Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cancer Hormone Therapy Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cancer Hormone Therapy Drugs market, reaching US$ million by the year 2028. As for the Europe Cancer Hormone Therapy Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cancer Hormone Therapy Drugs players cover Roche, Amgen, Pfizer, and Teva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Hormone Therapy Drugs market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Tamoxifen
• Aromatase Inhibitors
• Antiandrogens
• Androgen Synthesis Inhibitors
• Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Breast Cancer
• Prostate Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Roche
• Amgen
• Pfizer
• Teva
• Takeda
• Samyang Biopharmaceuticals
• Tolmar
• AstraZeneca
• Novartis
• Aspen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cancer Hormone Therapy Drugs Market Size 2017-2028
  2.1.2 Cancer Hormone Therapy Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Cancer Hormone Therapy Drugs Segment by Type
  2.2.1 Tamoxifen
  2.2.2 Aromatase Inhibitors
  2.2.3 Antiandrogens
  2.2.4 Androgen Synthesis Inhibitors
  2.2.5 Other
2.3 Cancer Hormone Therapy Drugs Market Size by Type
  2.3.1 Cancer Hormone Therapy Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Cancer Hormone Therapy Drugs Market Size Market Share by Type (2017-2022)
2.4 Cancer Hormone Therapy Drugs Segment by Application
  2.4.1 Breast Cancer
  2.4.2 Prostate Cancer
2.5 Cancer Hormone Therapy Drugs Market Size by Application
  2.5.1 Cancer Hormone Therapy Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Cancer Hormone Therapy Drugs Market Size Market Share by Application (2017-2022)

3 CANCER HORMONE THERAPY DRUGS MARKET SIZE BY PLAYER

3.1 Cancer Hormone Therapy Drugs Market Size Market Share by Players
  3.1.1 Global Cancer Hormone Therapy Drugs Revenue by Players (2020-2022)
  3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Cancer Hormone Therapy Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CANCER HORMONE THERAPY DRUGS BY REGIONS

4.1 Cancer Hormone Therapy Drugs Market Size by Regions (2017-2022)
4.2 Americas Cancer Hormone Therapy Drugs Market Size Growth (2017-2022)
4.3 APAC Cancer Hormone Therapy Drugs Market Size Growth (2017-2022)
4.4 Europe Cancer Hormone Therapy Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Cancer Hormone Therapy Drugs Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Cancer Hormone Therapy Drugs Market Size by Country (2017-2022)
5.2 Americas Cancer Hormone Therapy Drugs Market Size by Type (2017-2022)
5.3 Americas Cancer Hormone Therapy Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cancer Hormone Therapy Drugs Market Size by Region (2017-2022)
6.2 APAC Cancer Hormone Therapy Drugs Market Size by Type (2017-2022)
6.3 APAC Cancer Hormone Therapy Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cancer Hormone Therapy Drugs by Country (2017-2022)
7.2 Europe Cancer Hormone Therapy Drugs Market Size by Type (2017-2022)
7.3 Europe Cancer Hormone Therapy Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cancer Hormone Therapy Drugs by Region (2017-2022)
8.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CANCER HORMONE THERAPY DRUGS MARKET FORECAST

10.1 Global Cancer Hormone Therapy Drugs Forecast by Regions (2023-2028)
  10.1.1 Global Cancer Hormone Therapy Drugs Forecast by Regions (2023-2028)
  10.1.2 Americas Cancer Hormone Therapy Drugs Forecast
  10.1.3 APAC Cancer Hormone Therapy Drugs Forecast
  10.1.4 Europe Cancer Hormone Therapy Drugs Forecast
  10.1.5 Middle East & Africa Cancer Hormone Therapy Drugs Forecast
10.2 Americas Cancer Hormone Therapy Drugs Forecast by Country (2023-2028)
  10.2.1 United States Cancer Hormone Therapy Drugs Market Forecast
  10.2.2 Canada Cancer Hormone Therapy Drugs Market Forecast
  10.2.3 Mexico Cancer Hormone Therapy Drugs Market Forecast
  10.2.4 Brazil Cancer Hormone Therapy Drugs Market Forecast
10.3 APAC Cancer Hormone Therapy Drugs Forecast by Region (2023-2028)
  10.3.1 China Cancer Hormone Therapy Drugs Market Forecast
  10.3.2 Japan Cancer Hormone Therapy Drugs Market Forecast
  10.3.3 Korea Cancer Hormone Therapy Drugs Market Forecast
  10.3.4 Southeast Asia Cancer Hormone Therapy Drugs Market Forecast
  10.3.5 India Cancer Hormone Therapy Drugs Market Forecast
  10.3.6 Australia Cancer Hormone Therapy Drugs Market Forecast
10.4 Europe Cancer Hormone Therapy Drugs Forecast by Country (2023-2028)
  10.4.1 Germany Cancer Hormone Therapy Drugs Market Forecast
  10.4.2 France Cancer Hormone Therapy Drugs Market Forecast
  10.4.3 UK Cancer Hormone Therapy Drugs Market Forecast
  10.4.4 Italy Cancer Hormone Therapy Drugs Market Forecast
  10.4.5 Russia Cancer Hormone Therapy Drugs Market Forecast
10.5 Middle East & Africa Cancer Hormone Therapy Drugs Forecast by Region (2023-2028)
  10.5.1 Egypt Cancer Hormone Therapy Drugs Market Forecast
  10.5.2 South Africa Cancer Hormone Therapy Drugs Market Forecast
  10.5.3 Israel Cancer Hormone Therapy Drugs Market Forecast
  10.5.4 Turkey Cancer Hormone Therapy Drugs Market Forecast
  10.5.5 GCC Countries Cancer Hormone Therapy Drugs Market Forecast
10.6 Global Cancer Hormone Therapy Drugs Forecast by Type (2023-2028)
10.7 Global Cancer Hormone Therapy Drugs Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Cancer Hormone Therapy Drugs Product Offered
  11.1.3 Roche Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Amgen
  11.2.1 Amgen Company Information
  11.2.2 Amgen Cancer Hormone Therapy Drugs Product Offered
  11.2.3 Amgen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Amgen Main Business Overview
  11.2.5 Amgen Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Cancer Hormone Therapy Drugs Product Offered
  11.3.3 Pfizer Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Teva
  11.4.1 Teva Company Information
  11.4.2 Teva Cancer Hormone Therapy Drugs Product Offered
  11.4.3 Teva Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Teva Main Business Overview
  11.4.5 Teva Latest Developments
11.5 Takeda
  11.5.1 Takeda Company Information
  11.5.2 Takeda Cancer Hormone Therapy Drugs Product Offered
  11.5.3 Takeda Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Takeda Main Business Overview
  11.5.5 Takeda Latest Developments
11.6 Samyang Biopharmaceuticals
  11.6.1 Samyang Biopharmaceuticals Company Information
  11.6.2 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product Offered
  11.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 Samyang Biopharmaceuticals Main Business Overview
  11.6.5 Samyang Biopharmaceuticals Latest Developments
11.7 Tolmar
  11.7.1 Tolmar Company Information
  11.7.2 Tolmar Cancer Hormone Therapy Drugs Product Offered
  11.7.3 Tolmar Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 Tolmar Main Business Overview
  11.7.5 Tolmar Latest Developments
11.8 AstraZeneca
  11.8.1 AstraZeneca Company Information
  11.8.2 AstraZeneca Cancer Hormone Therapy Drugs Product Offered
  11.8.3 AstraZeneca Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 AstraZeneca Main Business Overview
  11.8.5 AstraZeneca Latest Developments
11.9 Novartis
  11.9.1 Novartis Company Information
  11.9.2 Novartis Cancer Hormone Therapy Drugs Product Offered
  11.9.3 Novartis Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 Novartis Main Business Overview
  11.9.5 Novartis Latest Developments
11.10 Aspen
  11.10.1 Aspen Company Information
  11.10.2 Aspen Cancer Hormone Therapy Drugs Product Offered
  11.10.3 Aspen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2020-2022)
  11.10.4 Aspen Main Business Overview
  11.10.5 Aspen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cancer Hormone Therapy Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Tamoxifen
Table 3. Major Players of Aromatase Inhibitors
Table 4. Major Players of Antiandrogens
Table 5. Major Players of Androgen Synthesis Inhibitors
Table 6. Major Players of Other
Table 7. Cancer Hormone Therapy Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Cancer Hormone Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Cancer Hormone Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 10. Cancer Hormone Therapy Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Cancer Hormone Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Cancer Hormone Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 13. Global Cancer Hormone Therapy Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Cancer Hormone Therapy Drugs Revenue Market Share by Player (2020-2022)
Table 15. Cancer Hormone Therapy Drugs Key Players Head office and Products Offered
Table 16. Cancer Hormone Therapy Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Cancer Hormone Therapy Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Cancer Hormone Therapy Drugs Market Size Market Share by Regions (2017-2022)
Table 21. Americas Cancer Hormone Therapy Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Cancer Hormone Therapy Drugs Market Size Market Share by Country (2017-2022)
Table 23. Americas Cancer Hormone Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Cancer Hormone Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 25. Americas Cancer Hormone Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Cancer Hormone Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 27. APAC Cancer Hormone Therapy Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Cancer Hormone Therapy Drugs Market Size Market Share by Region (2017-2022)
Table 29. APAC Cancer Hormone Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Cancer Hormone Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 31. APAC Cancer Hormone Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Cancer Hormone Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 33. Europe Cancer Hormone Therapy Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Cancer Hormone Therapy Drugs Market Size Market Share by Country (2017-2022)
Table 35. Europe Cancer Hormone Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Cancer Hormone Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 37. Europe Cancer Hormone Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Cancer Hormone Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Cancer Hormone Therapy Drugs
Table 46. Key Market Challenges & Risks of Cancer Hormone Therapy Drugs
Table 47. Key Industry Trends of Cancer Hormone Therapy Drugs
Table 48. Global Cancer Hormone Therapy Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Cancer Hormone Therapy Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Cancer Hormone Therapy Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Cancer Hormone Therapy Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Cancer Hormone Therapy Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Cancer Hormone Therapy Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 54. Roche Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 55. Roche Cancer Hormone Therapy Drugs Product Offered
Table 56. Roche Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Amgen Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 60. Amgen Cancer Hormone Therapy Drugs Product Offered
Table 61. Amgen Main Business
Table 62. Amgen Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Amgen Latest Developments
Table 64. Pfizer Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 65. Pfizer Cancer Hormone Therapy Drugs Product Offered
Table 66. Pfizer Main Business
Table 67. Pfizer Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Pfizer Latest Developments
Table 69. Teva Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 70. Teva Cancer Hormone Therapy Drugs Product Offered
Table 71. Teva Main Business
Table 72. Teva Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Teva Latest Developments
Table 74. Takeda Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 75. Takeda Cancer Hormone Therapy Drugs Product Offered
Table 76. Takeda Main Business
Table 77. Takeda Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Takeda Latest Developments
Table 79. Samyang Biopharmaceuticals Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 80. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product Offered
Table 81. Samyang Biopharmaceuticals Main Business
Table 82. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Samyang Biopharmaceuticals Latest Developments
Table 84. Tolmar Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 85. Tolmar Cancer Hormone Therapy Drugs Product Offered
Table 86. Tolmar Main Business
Table 87. Tolmar Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Tolmar Latest Developments
Table 89. AstraZeneca Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 90. AstraZeneca Cancer Hormone Therapy Drugs Product Offered
Table 91. AstraZeneca Main Business
Table 92. AstraZeneca Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. AstraZeneca Latest Developments
Table 94. Novartis Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 95. Novartis Cancer Hormone Therapy Drugs Product Offered
Table 96. Novartis Main Business
Table 97. Novartis Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Novartis Latest Developments
Table 99. Aspen Details, Company Type, Cancer Hormone Therapy Drugs Area Served and Its Competitors
Table 100. Aspen Cancer Hormone Therapy Drugs Product Offered
Table 101. Aspen Main Business
Table 102. Aspen Cancer Hormone Therapy Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Aspen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Hormone Therapy Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Hormone Therapy Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Cancer Hormone Therapy Drugs Market Size Market Share by Type in 2021
Figure 7. Cancer Hormone Therapy Drugs in Breast Cancer
Figure 8. Global Cancer Hormone Therapy Drugs Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 9. Cancer Hormone Therapy Drugs in Prostate Cancer
Figure 10. Global Cancer Hormone Therapy Drugs Market: Prostate Cancer (2017-2022) & ($ Millions)
Figure 11. Global Cancer Hormone Therapy Drugs Market Size Market Share by Application in 2021
Figure 12. Global Cancer Hormone Therapy Drugs Revenue Market Share by Player in 2021
Figure 13. Global Cancer Hormone Therapy Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Cancer Hormone Therapy Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Cancer Hormone Therapy Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Cancer Hormone Therapy Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Cancer Hormone Therapy Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Cancer Hormone Therapy Drugs Value Market Share by Country in 2021
Figure 19. Americas Cancer Hormone Therapy Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Cancer Hormone Therapy Drugs Market Size Market Share by Application in 2021
Figure 21. United States Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Cancer Hormone Therapy Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Cancer Hormone Therapy Drugs Market Size Market Share by Application in 2021
Figure 27. China Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Cancer Hormone Therapy Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Cancer Hormone Therapy Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Cancer Hormone Therapy Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Cancer Hormone Therapy Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Cancer Hormone Therapy Drugs Market Size 2023-2028 ($ Millions)